Search

Anemia is common in patients with aneurysmal subarachnoid hemorrhage (SAH), but these patients have constituted only a small fraction of those studied in large trials of anemia and transfusion. Unlike other critically ill patients, those with SAH face a well-defined risk of vasospasm and cerebral ischemia in the weeks after their hemorrhage. The risk of ongoing ischemia may make them less able to tolerate anemia and more likely to benefit from blood transfusion. The available data show that anemia is associated with poor outcomes after SAH but that blood transfusion does not consistently improve physiological markers, and it may be associated with poor outcomes. Most of these data are observational in nature, although 1 recent study demonstrated the safety and feasibility of maintaining relatively high transfusion thresholds in patients with SAH. Larger, randomized trials are needed to determine at what levels of anemia patients with SAH might benefit from transfusion, the optimal timing of transfusion, and how to identify those patients who are most likely to benefit.

Background: Clip application for temporary occlusion is not always practical or feasible. Adenosine is an alternative that provides brief periods of flow arrest that can be used to advantage in aneurysm surgery, but little has been published on its utility for this indication., Objective: To report our 2-year consecutive experience with 40 aneurysms in 40 patients for whom we used adenosine to achieve temporary arterial occlusion during aneurysm surgery., Methods: We retrospectively reviewed our clinical database between May 2007 and December 2009. All patients who underwent microsurgical clipping of intracranial aneurysms under adenosine-induced asystole were included. Aneurysm characteristics, reasons for adenosine use, postoperative angiographic and clinical outcome, cardiac complications, and long-term neurological follow-up with the modified Rankin Scale were noted., Results: Adenosine was used for 40 aneurysms (10 ruptured, 30 unruptured). The most common indications for adenosine were aneurysm softening in 17 cases and paraclinoid location in 14 cases, followed by broad neck in 12 cases and intraoperative rupture in 6 cases. Troponins were elevated postoperatively in 2 patients. Echocardiography did not show acute changes in either. Clinically insignificant cardiac arrhythmias were noted in 5 patients. Thirty-six patients were available for follow-up. Mean follow-up was 12.8 months. The modified Rankin Scale score was 0 for 29 patients at the time of the last follow-up. Four patients had an modified Rankin Scale score of 1, and scores of 2 and 3 were found in 2 and 1 patients, respectively., Conclusion: Adenosine appears to allow safe flow arrest during intracranial aneurysm surgery. This can enhance the feasibility and safety of clipping in select circumstances.

The question of accreditation and standardization of neuroanesthesia fellowship training programs in the U.S. has been discussed extensively within the field. Although numerous opinion pieces have been published, there are no data indicating the level of support or opposition for accreditation of subspecialty training among specialists in the field of neuroanesthesia. To address this gap in knowledge, a web-based survey was designed and electronically distributed to members of the Society of Neurosurgical Anesthesia and Critical Care (SNACC) that were practicing in the United States (n=339). The primary question assessed support for subspecialty accreditation. In addition, the participants were asked to rate the importance of various curricular elements for a neuroanesthesia fellowship training program. Over a 1-month period, there were 134 responses in total (40% of the sample). Ninety percent of the respondents identified themselves as having a university affiliation. Of the respondents, 64% indicated support for accreditation, 20% indicated opposition, and the remainder was equivocal. Career development, neurocritical care, and intraoperative neuromonitoring were the top 3 subjects thought to be essential to a neuroanesthesia fellowship. The majority supported a 1-year fellowship training program. These data indicate measurable support among members of SNACC for a process toward the accreditation of neuroanesthesia fellowship training programs.

Background: Adenosine-induced transient flow arrest has been used to facilitate clip ligation of intracranial aneurysms. However, the starting dose that is most likely to produce an adequate duration of profound hypotension remains unclear. We reviewed our experience to determine the dose-response relationship and apparent perioperative safety profile of adenosine in intracranial aneurysm patients., Methods: This case series describes 24 aneurysm clip ligation procedures performed under an anesthetic consisting of remifentanil, low-dose volatile anesthetic, and propofol in which adenosine was used. The report focuses on the doses administered; duration of systolic blood pressure <60 mm Hg (SBP(<60 mm Hg)); and any cardiovascular, neurologic, or pulmonary complications observed in the perioperative period., Results: A median dose of 0.34 mg/kg ideal body weight (range: 0.29-0.44 mg/kg) resulted in a SBP(<60 mm Hg) for a median of 57 seconds (range: 26-105 seconds). There was a linear relationship between the log-transformed dose of adenosine and the duration of a SBP(<60 mm Hg) (R(2) = 0.38). Two patients developed transient, hemodynamically stable atrial fibrillation, 2 had postoperative troponin levels >0.03 ng/mL without any evidence of cardiac dysfunction, and 3 had postoperative neurologic changes., Conclusions: For intracranial aneurysms in which temporary occlusion is impractical or difficult, adenosine is capable of providing brief periods of profound systemic hypotension with low perioperative morbidity. On the basis of these data, a dose of 0.3 to 0.4 mg/kg ideal body weight may be the recommended starting dose to achieve approximately 45 seconds of profound systemic hypotension during a remifentanil/low-dose volatile anesthetic with propofol induced burst suppression.

Objective: The purpose of this study was to examine the utility and feasibility of using alternative anterior reference leads when measuring left posterior tibial nerve somatosensory evoked potentials (SEPs)., Methods: With IRB approval, 12 patients were monitored using both traditional (FPz and C4') and alternative anterior (F3 and F4) reference leads during routine spine surgery with SEP monitoring. Recordings from the routine and novel electrode pairs were collected and analyzed., Results: All of the SEP amplitudes measured were of similar magnitude except for that of F3-F4, which was significantly lower (P < 0.001) than all of the other five lead combinations which were assessed (Cz'-FPz, C3'-C4', C3'-F4, Cz'-F3, and Cz'-F4). The latencies of the novel lead combinations (C3'-F4, Cz'-F3, Cz'-F4, and F3-F4) were similar to those of the "gold standards" (Cz'-FPz and C3'-C4') (pooled median, 45.6 ms with 25-75th percentiles, 44.0-47.8 ms, P = 0.308). The coefficients of variation (CV %) of the amplitudes were not statistically significantly different (P = 0.341)., Conclusions: The use of alternative frontal reference leads (F3 and F4) for left posterior tibial nerve SEP monitoring yields signals of equal quality and reproducibility compared to signals with standard (FPz and C4') referencing. These alternative leads may substitute for traditional referencing when placement of FPz or C4' is precluded by the location of surgery.

We have studied the effects of a single i.v. dose of sufentanil 5 micrograms kg-1 in combination with pancuronium on the median nerve short latency somatosensory evoked potentials (SSEP) in 15 unpremedicated patients undergoing thoracic or lumbar spinal surgery. The latency and amplitude of the SSEP response over the second cervical vertebra (SC) and sensory cortex (P17, N20, P25), heart rate and arterial pressure were recorded for 30 min after the injection of sufentanil. A significant increase in mean latency occurred for N20 (P less than 0.003) and P25 (P less than 0.002) within 2 min, but the absolute increase in latency was small. The mean amplitudes of all peaks decreased to 60% (SC), 70% (P17), 60% (N20) (P less than 0.012) and 45% (P25) of the baseline value within 7 min. The results suggest that the major change in median nerve SSEP produced by this dose of sufentanil is a reduction in amplitude, and that major changes in latency after sufentanil and pancuronium are probably caused by other influences.

Somatosensory evoked potentials (SEPs) were monitored during 113 operations for the clipping of 134 cerebral aneurysms. Changes in peak latency and amplitude of early cortical SEP as well as central conduction time were evaluated. In 58 cases surgical occlusion of arterial vessels or other events occurred, and in 17 of these cases such events were associated with SEP changes or loss. Arterial occlusions resulted from temporary clipping of a feeding blood vessel (22), accidental clipping of a vessel (12), and intentional permanent vessel occlusion (8). A total SEP loss was seen in 2 cases of accidental vessel occlusion and in 6 cases of temporary vessel clipping. Significant SEP changes were found in 6 patients with temporary clipping, and once each with retraction of the cerebellum, retraction of the middle cerebral artery, and after intentional permanent vessel occlusion. Response to these changes included reapplication of aneurysm clips, repositioning of retractors, or removal of temporary clips. Stable SEP signals during 13 cases allowed the surgeon to proceed with the surgical course. Despite the limitations of SEP monitoring in certain anatomical locations, it has been found to be helpful in the operative management of some cases such as multilobed aneurysms of the middle cerebral artery, giant aneurysms, trapping procedures, and procedures requiring temporary vessel occlusion.

Hypokalemia (mean serum potassium 2.3 +/- 0.4 mEq/l) was observed in six hypothermic patients (30 degrees - 32 degrees C) with head injuries or brain hypoxia. In the first three patients, potassium was administered to maintain serum levels above 3.5 mEq/l and on rewarming after 48 h of hypothermia hyperkalemia (peak serum potassium = 7.1 +/- 0.5 mEq/l) associated with cardiac arrhythmias developed. The remaining three patients received sufficient potassium to approximately replace measured losses during the hypothermic period. These patients did not become hyperkalemic on rewarming. Clinically insignificant sinus bradycardia, premature atrial contractions and junctional rhythms were seen during hypothermia with hypokalemia. We conclude that hypothermia produces hypokalemia by a shift of potassium from the extracellular to intracellular or extra vascular spaces. Potassium therapy during controlled hypothermia in the range 30 degrees - 32 degrees C should only replace measured losses.

Evoked potentials are increasingly used for intraoperative monitoring. Their use is based on their ability to detect early changes caused by surgical maneuvers which may result in post operative deficits. However, not all changes are surgically related and any decrease in the non surgical causes of evoked potential changes increases the yield of intraoperative monitoring. In this review I will discuss the anesthetic effects on evoked potentials; these include a general description of the anesthetic effects on evoked potentials followed by the effects of premedication, induction, and maintenance agents. Also, described are the effects of adjunct anesthetic agents and techniques. Changes related to anesthesia are not similar and the knowledge of such differences is essential for the planing of anesthesia during the use of evoked potentials. An out line of the anesthetic techniques are described at the end of this review.

The laser has been welcomed to the neurosurgical armamentarium because of the inherent precision and gentleness of the no-touch technique. In order to maximize laser safety and efficacy, however, certain anesthesiologic considerations, specific to neurosurgery, must be realized. Motion of patient (target) during routine anesthesiologic checks or as the result of physiologic excursions during myocardial contraction and respiration must be minimized. Ventilatory parameters, anesthetic agents, and cardio active drugs are considered.